Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-21
2011-06-21
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S151000
Reexamination Certificate
active
07964623
ABSTRACT:
This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereofwherein R1and R2are independently of each other hydrogen atom, C1-6alkyl group or C6-14aryl group, R3is hydrogen atom or C1-6alkylcarbonyloxy group, or together with R4forms a bond, R4is hydrogen atom, or together with R3forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R5is hydrogen atom or C1-6alkyl group, R6is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, amino group, C1-6alkylamino group, di-C1-6alkylamino group, C6-14arylamino group, C2-9heteroarylamino group, C6-14aryl group, C2-9heteroaryl group or C2-9heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.
REFERENCES:
patent: 4900752 (1990-02-01), Seto et al.
patent: 5164509 (1992-11-01), Atwal
patent: 5319089 (1994-06-01), Matsumoto et al.
patent: 5843989 (1998-12-01), Vong et al.
patent: 5919806 (1999-07-01), Seto et al.
patent: 0 327 127 (1989-08-01), None
patent: 0 409 165 (1991-01-01), None
patent: 0 488 107 (1992-06-01), None
patent: 0 693 283 (1996-01-01), None
patent: A 58-67683 (1983-04-01), None
patent: A 2-4791 (1990-01-01), None
patent: WO 95/34547 (1995-12-01), None
patent: WO 99/62867 (1999-12-01), None
patent: WO 00/12492 (2000-03-01), None
patent: WO 00/58300 (2000-10-01), None
patent: WO 01/21609 (2001-03-01), None
patent: WO 01/21610 (2001-03-01), None
patent: WO 01/25224 (2001-04-01), None
patent: WO 02/064581 (2002-08-01), None
patent: WO 03/000675 (2003-01-01), None
patent: WO 03/014113 (2003-02-01), None
Chan, Wai N. et al. “Conformational Preference of the 6-acetyl Group in Novel Anticonvulsanttrans4s-benzamido-benzo[b]pyran-3r-ols;”Bioorganic&Medicinal Chemistry Letters, vol. 7, No. 12, pp. 1573-1576, 1997.
Matsuda Tomoyuki
Ohrai Kazuhiko
Okada Takumi
Shigeta Yukohiro
Uesugi Osamu
Nissan Chemical Industries Ltd.
Oliff & Berridg,e PLC
Solola Taofiq A
LandOfFree
Tricyclic benzopyrane compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic benzopyrane compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic benzopyrane compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2728525